Skip to main content

Table 2 Comparison of selected PK parameters among VEGF inhibitors

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Inhibitor

pI

Dose (mg/kg)

Cmax(μg/ml)

AUC (μg · days/ml)

Reference

HB-002.1

6.7

2.5

20.3

81.46

This study

Bevacizumab

7.6

9.3

74.1

682

39

Parental VEGF-Trap

9.4

4.0

0.05

0.04

24

VEGF-TRAP∆B1

9.1

4.0

1.3

1.36

24

VEGF-TRAP∆B2

8.9

4.0

2.65

5.42

24

Aflibercept

8.82

4.0

16

36.28

24